Authors:
Preeti Wadhwani, Manish Verma
Download free PDF
Ambulance Market Size & Share 2026-2035
Report ID: GMI9486
|
Published Date: October 2026
|
Report Format: PDF/Excel/Dashboard/Platform
Explore Our Licensing Options:
Ambulance Market
Get a free sample of this report
What are you hoping to find?
Your PDF is on its way. Tell us little about your research goal, and we'll help you find the most relevant market insights.
Ambulance Market Size
The ambulance market was valued at USD 7.86 billion in 2025, is projected to reach USD 8.37 billion in 2026, and is expected to grow at a 6.5% CAGR (2026–2035) to reach USD 14.76 billion by 2035. The market covers purpose-built ground emergency medical vehicles and integrated clinical equipment sold with the vehicle, spanning truck-chassis, van-conversion, cutaway, and medium-duty configurations across ICE and EV/Hybrid platforms.
Ambulance Market Key Takeaways
Market Leader: Braun Industries led with over 10.5% market share in 2025.
Leading Players: Top 5 players in this market include Braun Industries, WAS, Demers Ambulances, Force Motors, Frazer Ltd, which collectively held a market share of 35% in 2025.
Revenue growth reflects a widening divide between premiumization in mature health systems and volume-led capacity building in emerging markets. Advanced life-support specifications, electrified platforms, climate-control requirements, and onboard clinical equipment are raising revenue per vehicle in developed markets, while new EMS network deployment is expanding unit demand in less penetrated markets.
GMI Analyst View
Based on our analysis of government procurement data, vehicle registration records, and fleet deployment data across key markets, the global ambulance market comprised approximately 69,970 ambulance units in 2025. We view the divergence between vehicle volumes and revenue as a defining market characteristic: increasingly stringent clinical, safety, and zero-emission requirements are shifting procurement toward more highly specified vehicles, particularly within developed health systems.
Ambulance Market Trends, Growth Drivers & GMI Forecast Outlook
Ambulance demand is being shaped by an intersection of rising emergency-care requirements, public-fleet electrification, and uneven fiscal capacity among buyers. Procurement growth will remain strongest where network expansion or regulation creates defined replacement needs, while staffing shortages and charging-infrastructure costs constrain fleet expansion in budget-sensitive systems.
Key Drivers
Evidence anchors use cited external data; demand implications and forecast conditions represent GMI analysis.
Population ageing alters ambulance procurement not merely by increasing transport demand, but by changing the clinical profile of callouts. Higher incidence of cardiac, respiratory, neurological, and fall-related emergencies requires equipment-intensive vehicles capable of delivering advanced intervention before hospital arrival. In North America and Europe, this supports replacement demand for ALS-capable platforms and raises the importance of onboard monitoring, powered stretchers, communications systems, and climate management.
Fleet electrification is also moving from exploratory trials to a specification issue in public procurement. Buyers confronting net-zero commitments must assess range, battery management, auxiliary power, thermal resilience, depot charging, and clinical-equipment load together rather than treating propulsion as a standalone chassis decision. This favors manufacturers that can certify an integrated vehicle package, sustain service support, and manage the engineering complexity of electrified ambulance operations.
Emerging-market demand follows a different route. National emergency-number deployment, hospital-network investment, and new station construction create requirements for incremental fleet availability rather than replacement alone. Cost-effective, serviceable vehicle formats remain important for broad geographic coverage, although larger urban providers are increasingly seeking higher clinical specifications and more standardized procurement criteria.
Key Restraints
Evidence anchors use cited external data; demand implications and forecast conditions represent GMI analysis.
Workforce scarcity limits the operational case for immediate fleet expansion. Agencies facing difficulty recruiting and retaining EMTs and paramedics often prioritize staffing expenditures, overtime coverage, and workforce stabilization over additional vehicle capacity. The effect is most acute in rural and fiscally constrained systems, where a fleet can be physically available but cannot be fully crewed, weakening the rationale for incremental vehicle purchases.
Electrification presents a second constraint because fleet transition costs extend beyond vehicle acquisition. Depot electrical capacity, charger placement, route planning, maintenance capability, resilience procedures, and staff training become material elements of a procurement decision. Buyers with dedicated capital funding can move earlier, whereas smaller operators may retain ICE vehicles longer even where regulatory direction is clear.
Certification fragmentation further protects established suppliers. Manufacturers need to reconcile vehicle engineering with national safety specifications, clinical layouts, local chassis availability, and testing requirements. This creates a practical advantage for regionally embedded converters with existing approvals and customer relationships, while increasing the cost and time required for entrants to scale across borders.
GMI Analyst View
We believe electrification will reshape competitive positioning before it fully reshapes global fleet composition. Suppliers able to combine certified EV platforms with dependable clinical integration and after-sales support should gain greater access to regulated public tenders. At the same time, workforce pressure will keep procurement decisions disciplined, favoring replacements that improve fleet reliability and operating capability over indiscriminate capacity expansion.
Ambulance Market Segment Analysis
By Vehicle Type
Type I ambulances generated USD 2.13 billion in 2025 and are projected to expand at a 7.5% CAGR (2026–2035). Their truck-chassis design supports heavier clinical payloads, greater equipment integration, and high-duty-cycle use, making the configuration particularly relevant to advanced life-support fleets and demanding geographic operating conditions.
Type III ambulances are forecast to reach USD 4.06 billion by 2035 and represented 27.3% of revenue in 2025. The configuration continues to offer a practical balance between interior treatment capacity and chassis flexibility, which supports its widespread use among municipal EMS providers and commercial operators seeking adaptable ALS-ready vehicles.
Medium-Duty ambulances are projected to reach USD 1.11 billion by 2035 and are expected to grow at an 8.0% CAGR (2026–2035). Demand is supported by applications that require a greater payload margin than typical van platforms can provide, while avoiding the cost and operating profile of a full truck-based vehicle.
Others vehicle configurations generated USD 360.3 million in 2025 and are forecast to decline at a −0.5% CAGR (2026–2035). Tightening procurement standards and a stronger preference for certified, clinically equipped platforms are reducing the relevance of lower-specification conversions in formal public and institutional purchasing channels.
By Propulsion
ICE ambulances accounted for 88.0% of revenue in 2025 and are expected to retain a 70.0% share by 2035. Their continued dominance reflects established fueling infrastructure, broad chassis availability, and the operational constraints faced by buyers without the capital or depot readiness for electrified fleets.
EV/Hybrid ambulances generated USD 943.5 million in 2025 and are projected to grow at a 16.4% CAGR (2026–2035). Adoption is being led by buyers that can accommodate charging infrastructure and specify vehicles around zero-emission mandates, though vehicle range, auxiliary-power needs, and charging resilience remain central considerations for emergency-service operators.
By Application
Emergency Medical Services ambulances generated USD 4.88 billion in 2025 and are expected to grow at a 6.9% CAGR (2026–2035). This application remains the market's principal demand base because it is directly tied to emergency-response coverage, rising call complexity, and the replacement requirements of public and private EMS fleets.
Non-Emergency Patient Transport held an 18.0% revenue share in 2025 and is projected to expand at a 7.1% CAGR (2026–2035). The segment benefits from health-system efforts to separate lower-acuity patient movement from emergency response, creating fleet requirements shaped by patient comfort, accessibility, uptime, and commercially managed scheduling.
Fire & Rescue ambulances are projected to reach USD 1.33 billion by 2035 and represented 10.0% of revenue in 2025. Demand is influenced by the ability of fire departments to use multi-role fleet assets, although budget priorities often favor extending vehicle life and adapting existing equipment over immediate dedicated purchases.
Military ambulances are forecast to reach USD 590.4 million by 2035 and are expected to grow at a 4.2% CAGR (2026–2035). Procurement is shaped by defense investment cycles and specialized requirements for mobility, protection, and deployability, producing a more episodic purchasing pattern than civilian emergency-care applications.
Others applications generated USD 393.1 million in 2025 and are projected to account for 3.0% of revenue by 2035. Regulatory enforcement and broader use of compliant ambulance platforms are narrowing the role of non-certified and specialized transport configurations in institutional procurement.
By End Use
Government/Municipal EMS generated USD 3.30 billion in 2025 and is expected to grow at a 5.9% CAGR (2026–2035). This buyer group provides predictable replacement demand, but purchasing remains exposed to annual appropriations, municipal fiscal capacity, labor costs, and decisions to extend vehicle service life.
Public Hospital Systems are projected to reach USD 2.80 billion by 2035 and held a 20.0% revenue share in 2025. Hospital-led fleet demand is supported by integrated care models that require reliable emergency, interfacility, and patient-transfer capability across increasingly coordinated health networks.
Military & Defense ambulance demand is forecast to reach USD 1.18 billion by 2035 and is expected to grow at a 4.2% CAGR (2026–2035). The segment prioritizes vehicle durability, mission suitability, and specialized medical capability, with purchasing timing determined by broader defense modernization and readiness programs.
Private EMS Companies generated USD 1.18 billion in 2025 and are anticipated to grow at an 8.6% CAGR (2026–2035). Commercial providers are increasingly important buyers where ambulance services are outsourced or where NEPT operations are expanding, placing greater emphasis on vehicle uptime, operating economics, and fleet standardization.
Private Healthcare Institutions are projected to reach USD 1.62 billion by 2035 and represented 9.0% of revenue in 2025. Expansion of private hospitals, specialty-care providers, and premium patient-transport services is creating demand for ambulances that offer higher clinical specification and brand-differentiating service quality.
Industrial & Mining accounted for 4.0% of revenue in 2025 and is forecast to reach USD 590.4 million by 2035. Remote-site operators require first-response capability that can function in difficult terrain and under occupational-health obligations, creating a specialized demand base distinct from conventional municipal EMS procurement.
GMI Analyst View
We see a gradual shift in purchasing influence toward buyers that evaluate ambulances as operating assets rather than solely as public-service equipment. Private EMS, patient-transport, and hospital operators place greater weight on uptime, whole-life cost, clinical layout, and fleet utilization. That preference should reward manufacturers able to offer configurable vehicles, dependable service support, and propulsion options suited to different operating environments.
Ambulance Market Regional Analysis
North America Ambulance Market Analysis
The Ambulance Market in North America generated USD 3.43 billion in 2025 and is projected to grow at a 5.6% CAGR (2026–2035). The region combines high clinical specifications, fragmented local procurement, and established domestic conversion capacity, supporting high revenue per vehicle while workforce shortages and mature fleet penetration moderate incremental volume demand.
US
The US ambulance market generated USD 3.14 billion in 2025 and is projected to reach USD 5.47 billion by 2035. Decentralized procurement by municipal, county, fire-based, hospital, and private EMS agencies sustains demand for specialized vehicle configurations and reinforces the importance of cooperative purchasing access, regulatory familiarity, and regional service coverage.
Canada
Canada generated USD 290.8 million in 2025 and is projected to grow at a 5.4% CAGR (2026–2035). Provincial health-authority procurement and a need for both emergency and patient-transfer capacity support a comparatively structured demand environment, while domestic manufacturing consolidation may influence investment capacity and distribution reach.
Europe Ambulance Market Analysis
Europe generated USD 2.00 billion in 2025 and is projected to grow at a 5.2% CAGR (2026–2035). The Ambulance Market in Europe is characterized by stringent vehicle certification, mature public EMS systems, and a growing role for private patient transport, while electrification requirements are adding technical complexity and lifting vehicle specifications.
Germany
Germany is projected to reach USD 557.7 million by 2035 and accounted for 16.4% of European revenue in 2025. Its emergency-service structure supports demand for technically advanced, certified vehicles, and the presence of established domestic specialist manufacturers reinforces a market centered on engineering quality and local operator requirements.
UK
The UK generated USD 454.0 million in 2025 and is expected to grow at a 5.0% CAGR (2026–2035). National health-system procurement frameworks and zero-emission fleet objectives create a defined pathway for electrified ambulance purchasing, although implementation remains tied to trust-level capital planning and operational readiness.
France
France represented 12.7% of European ambulance revenue in 2025 and is forecast to reach USD 422.7 million by 2035. The coexistence of hospital-led emergency response and private transport provision produces differentiated requirements for mobile intensive-care vehicles and lower-acuity patient-transfer fleets.
Italy
Italy generated USD 169.2 million in 2025 and is projected to grow at a 4.8% CAGR (2026–2035). Regional fragmentation in health-service procurement and fiscal pressure on public systems constrain large-scale modernization, although replacement demand remains tied to service continuity and clinical compliance.
Spain
Spain is projected to reach USD 210.5 million by 2035 and accounted for 6.5% of European revenue in 2025. Public-private service models support multi-year vehicle demand through contracted emergency and patient-transport operations, giving procurement decisions a stronger operating-model component than in wholly public systems.
Russia
Russia generated USD 228.9 million in 2025 and is expected to grow at a 3.5% CAGR (2026–2035). Supply-chain constraints and limited access to some imported components complicate adoption of higher-specification platforms, increasing the relevance of domestic vehicle production and localized service capacity.
Netherlands
The Netherlands is projected to reach USD 78.4 million by 2035 and represented 2.3% of European revenue in 2025. Despite its limited fleet scale, the country's demanding clinical protocols support selective procurement of premium, highly equipped ambulances.
Belgium
Belgium generated USD 20.6 million in 2025 and is projected to reach USD 34.2 million by 2035. Demand is supported by public emergency-service renewal and inter-hospital transport activity, with procurement varying across regional service structures.
Sweden
Sweden held a 1.3% revenue share in Europe in 2025 and is projected to grow at a 5.8% CAGR (2026–2035). Regional authority modernization programs and a strong institutional focus on lower-emission transport support demand for progressively more electrification-ready ambulance specifications.
Asia Pacific Ambulance Market Analysis
Asia Pacific generated USD 1.79 billion in 2025 and is projected to expand at an 8.5% CAGR (2026–2035). The Ambulance Market in Asia Pacific is the principal growth engine, supported by expanding emergency-response coverage, healthcare investment, private-hospital development, and the increasing formalization of vehicle standards across diverse national markets.
China
China generated USD 806.2 million in 2025 and is projected to reach USD 1.91 billion by 2035. Central and local health-system procurement, expanding coverage in lower-tier cities, and a deep domestic chassis base underpin demand, while premium hospital fleets create a parallel market for more advanced clinical configurations.
Japan
Japan is projected to reach USD 303.2 million by 2035 and is expected to grow at a 3.5% CAGR (2026–2035). The country's highly developed emergency-service infrastructure creates a replacement-led market in which fleet quality, standardization, and operational reliability outweigh broad-based capacity expansion.
India
India generated USD 268.7 million in 2025 and is projected to grow at a 12.5% CAGR (2026–2035). Public emergency-number programs, state-led fleet deployment, and private-hospital expansion are creating demand across both basic life-support and higher-acuity vehicle formats, supporting a substantial role for cost-optimized domestic manufacturing.
South Korea
South Korea generated USD 143.3 million in 2025 and is expected to grow at a 5.5% CAGR (2026–2035). Fleet modernization by emergency authorities and demand from private healthcare providers support procurement of clinically advanced vehicles aligned with high operating and treatment standards.
Australia
Australia is projected to reach USD 222.6 million by 2035 and represented 8.0% of Asia Pacific revenue in 2025. State-run ambulance services and private patient-transport operators sustain demand for well-equipped fleets, while vehicle trials and procurement planning are gradually incorporating electrification considerations.
Indonesia
Indonesia is projected to reach USD 203.5 million by 2035 and is expected to grow at an 11.0% CAGR (2026–2035). Health-center expansion and broader emergency-service infrastructure development are increasing requirements for competitively priced, serviceable ambulance platforms suited to geographically dispersed operations.
Vietnam
Vietnam generated USD 35.8 million in 2025 and is projected to reach USD 121.6 million by 2035. Urbanization, healthcare investment, and the emergence of private hospital networks are expanding demand for emergency and patient-transfer fleets, particularly in major metropolitan areas.
Malaysia
Malaysia accounted for 2.0% of Asia Pacific revenue in 2025 and is projected to grow at an 8.0% CAGR (2026–2035). Hospital-linked fleet development and increasing private-sector healthcare activity are broadening the buyer base beyond traditional public emergency-service procurement.
Singapore
Singapore generated USD 17.9 million in 2025 and is projected to reach USD 25.3 million by 2035. Its compact, high-specification EMS environment favors advanced clinical equipment and fleet reliability, while sustainability objectives are likely to influence future vehicle evaluations.
Latin America Ambulance Market Analysis
Latin America generated USD 318.0 million in 2025 and is projected to grow at a 7.0% CAGR (2026–2035). The Ambulance Market in Latin America is supported by public health-system investment and urban private EMS demand, although macroeconomic instability, import dependence, and uneven municipal financing can delay procurement programs.
Brazil
Brazil generated USD 143.1 million in 2025 and is projected to reach USD 281.4 million by 2035. Public emergency-response programs remain the principal demand anchor, supplemented by private EMS activity in major metropolitan markets and a growing need for hospital-connected patient transport.
Mexico
Mexico is projected to reach USD 196.6 million by 2035 and represented 30.0% of Latin American revenue in 2025. Demand spans public health and humanitarian procurement, social-security health networks, and private hospitals, creating a broad range of vehicle requirements from basic transport to advanced clinical response.
Argentina
Argentina generated USD 31.8 million in 2025 and is expected to grow at a 5.5% CAGR (2026–2035). Inflation, currency pressure, and constrained public capital budgets weigh on replacement velocity, making fleet maintenance and phased purchases important features of local demand.
Middle East & Africa Ambulance Market Analysis
Middle East & Africa generated USD 323.6 million in 2025 and is projected to grow at a 7.5% CAGR (2026–2035). The Ambulance Market in Middle East & Africa is driven by Gulf healthcare infrastructure investment and expanding emergency-care provision, while the wider region remains differentiated by uneven public funding, local service capability, and clinical infrastructure.
Saudi Arabia
Saudi Arabia generated USD 106.8 million in 2025 and is projected to reach USD 241.4 million by 2035. Public emergency-service procurement and healthcare-infrastructure investment are expanding fleet requirements, while new health developments are creating demand for both public and private ambulance capacity.
UAE
The UAE is projected to reach USD 153.7 million by 2035 and represented 22.0% of Middle East & Africa revenue in 2025. High-acuity emergency care, inter-hospital transport requirements, and centralized health-authority purchasing support demand for premium, clinically equipped ambulance platforms.
South Africa
South Africa represented 15.0% of Middle East & Africa revenue in 2025 and is projected to grow at a 6.5% CAGR (2026–2035). A divided public and private service structure creates demand across a broad specification range, with private providers often requiring more advanced vehicles and differentiated service capability.
GMI Analyst View
We view regional divergence as the central strategic challenge for ambulance manufacturers. Mature markets reward compliance, clinical sophistication, and fleet-transition capability, whereas capacity-building markets favor localized service, cost discipline, and scalable vehicle availability. Suppliers that attempt to apply a single product and channel model across both environments may struggle to balance premium engineering requirements with emerging-market affordability.
Ambulance Market Share & Competitive Landscape
Top 5 players in this market include Braun Industries, WAS, Demers Ambulances, Force Motors, Frazer, which collectively held a market share of 35% in 2025. Competition is shaped by local certification, chassis relationships, clinical-equipment integration, distribution reach, and the ability to support customers through long fleet life cycles rather than by scale alone.
Braun Industries held a 10.5% global market share in 2025. Its North American position is reinforced by its strength in Type I and Type III configurations, established municipal procurement access, and capabilities in integrating advanced life-support equipment for higher-specification fleet buyers.
WAS held a 7.8% global market share in 2025. The company's European position is supported by specialization in certified ambulance platforms, familiarity with CEN EN 1789 requirements, and relationships with emergency-service and hospital buyers seeking premium clinical layouts.
Demers Ambulances accounted for a 6.2% global market share in 2025. Its competitive standing is linked to a substantial North American operating base, differentiated vehicle modules, and an ability to address procurement requirements where ergonomics, reliability, and service support influence buyer decisions.
Force Motors is positioned around localized, cost-competitive procurement in India's public EMS environment, where manufacturing proximity and familiarity with government tender channels are strategic advantages. Its challenge is to extend relevance where higher clinical specifications and different certification regimes are required.
Frazer competes through custom ambulance modules and remount capabilities for operators seeking tailored clinical configurations or longer asset utilization. This model serves specialized buyers well but has a narrower addressable market than standardized high-volume fleet platforms.
Other relevant competitors include Crestline Coach, Ambulanz Mobile, Tata Motors, BINZ Ambulanz, NAFFCO, Life Line Emergency Vehicles, AEV Limited, SIV Ambulances, Wright Industries, Harbinger Motors, Rosenbauer International, and Terex. Their relative positions depend heavily on local approvals, service networks, chassis partnerships, and the ability to respond to a market moving toward greater clinical integration and electrification readiness.
Recent Industry Developments
J.B. Poindexter & Co., Inc. Acquires Demers Braun Crestline Medix - June 2025
J.B. Poindexter & Co., Inc. completed its acquisition of Demers Braun Crestline Medix in June 2025, combining Demers, Braun, Crestline, and Medix within a larger North American manufacturing platform. The transaction strengthens access to manufacturing resources, distribution, and product-development investment for the combined ambulance business [4]BusinessWire / J.B. Poindexter & Co., Inc. "J.B. Poindexter & Co., Inc. Acquires Ambulance Manufacturing Leader Demers Braun Crestline Medix." businesswire.com.
Wright Industries and Model 1 Commercial Vehicles Launch Nationwide U.S. Distribution Partnership - October 2025
Wright Industries entered a nationwide distribution partnership with Model 1 Commercial Vehicles in October 2025. The agreement gives Wright Industries access to a wider U.S. sales and service footprint, strengthening its route to market as a newer entrant in the North American ambulance manufacturing segment [5]BusinessWire / Model 1 Commercial Vehicles. "Model 1 Commercial Vehicles Named First Nationwide Dealer for New Wright Industries Ambulances." businesswire.com.
Need a specific section of this report?
Purchase regional analysis, country-level analysis, company profiles, or any other segment-level insights separately
based on your research needs.
Frequently Asked Questions (FAQs):
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Industry journals, trade publications, and specialized media.
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 20+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →